Capital Flow Monitor · Sponsors · CIK 1650557
Genomenon, Inc.
206 E. Huron Street, ANN ARBOR, MI, 48104 · 734-794-3075
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$10.0M
Sold
$6.0M
% sold
60.3%
Investors
30
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-30 | D ·current | 506(b) | $10.0M | $6.0M | 60.3% | 30 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- Michael Klein — Executive Officer / Director, Ann Arbor, MI
- Mark Kiel — Executive Officer / Director, Ann Arbor, MI
- Patricia Glaza — Director, Ann Arbor, MI
- David Gregorka — Director, Ann Arbor, MI
- Michael Gross — Director, Ann Arbor, MI
- Brian Groark — Executive Officer, Ann Arbor, MI
- Sam Globus — Executive Officer, Ann Arbor, MI
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.